Leadership Study Description: Now that you’ve gone through the independent rebuild process, apply your knowledge to your team (personal or professional) so they can be onboard with what you want to do to protect the inner work that you’ve done!
Speaker: Dr. Megan Coylewright
In her position as Director of the Structural Heart Program at The Erlanger Heart and Lung Institute, Dr. Megan Coylewright is leading a highly skilled heart team to treat valvular and structural heart disease. The heart team at Erlanger is also expanding regional access to state-of-the-art cardiovascular device clinical trials. Dr. Coylewright serves as the PI for multiple trials, and is on the global steering committee for CHAMPION AF, a large study comparing DOACs to Watchman for stroke prevention and EXPAND II, a study of TAVR in moderate aortic stenosis. Dr. Coylewright’s research focused on diversity, equity and inclusion compliments her role as Vice Chief of Cardiology for Faculty Development within southern Tennessee’s only academic cardiovascular program.
As a frequent lecturer on structural heart topics, healthy policy, and shared decision making, Dr. Coylewright serves on the planning committees and faculty for the Scientific Sessions of ACC and TCT and is the 2022 Structural Heart Program Lead for SCAI’s Annual Meeting. She contributes to multiple national guideline writing committees on both technical topics and professionalism and ethics. She was selected for the Emerging Leader Mentorship Program of SCAI and the Emerging Faculty Program for ACC.
In 2021, Dr. Coylewright was selected to serve as Editor for CardioSmart, the American College of Cardiology’s Patient Engagement program.
Dr. Coylewright completed her medical school, residency, and Master of Public Health training at John Hopkins, and served as Health Disparities Coordinator at the Baltimore City Public Health Department. Five years of cardiovascular training were spent at the Mayo Clinic in her home state of Minnesota, finishing with an Advanced Interventional Cardiology fellowship in Structural Heart Disease.
Leadership Study Description: Now that you’ve gone through the independent rebuild process, apply your knowledge to your team (personal or professional) so they can be onboard with what you want to do to protect the inner work that you’ve done!
Speaker: Dr. Megan Coylewright
In her position as Director of the Structural Heart Program at The Erlanger Heart and Lung Institute, Dr. Megan Coylewright is leading a highly skilled heart team to treat valvular and structural heart disease. The heart team at Erlanger is also expanding regional access to state-of-the-art cardiovascular device clinical trials. Dr. Coylewright serves as the PI for multiple trials, and is on the global steering committee for CHAMPION AF, a large study comparing DOACs to Watchman for stroke prevention and EXPAND II, a study of TAVR in moderate aortic stenosis. Dr. Coylewright’s research focused on diversity, equity and inclusion compliments her role as Vice Chief of Cardiology for Faculty Development within southern Tennessee’s only academic cardiovascular program.
As a frequent lecturer on structural heart topics, healthy policy, and shared decision making, Dr. Coylewright serves on the planning committees and faculty for the Scientific Sessions of ACC and TCT and is the 2022 Structural Heart Program Lead for SCAI’s Annual Meeting. She contributes to multiple national guideline writing committees on both technical topics and professionalism and ethics. She was selected for the Emerging Leader Mentorship Program of SCAI and the Emerging Faculty Program for ACC.
In 2021, Dr. Coylewright was selected to serve as Editor for CardioSmart, the American College of Cardiology’s Patient Engagement program.
Dr. Coylewright completed her medical school, residency, and Master of Public Health training at John Hopkins, and served as Health Disparities Coordinator at the Baltimore City Public Health Department. Five years of cardiovascular training were spent at the Mayo Clinic in her home state of Minnesota, finishing with an Advanced Interventional Cardiology fellowship in Structural Heart Disease.